Importantly, the expression of Helios in CD4+ T cells was significantly increased in rheumatoid arthritis (RA) patients who were successfully treated with tocilizumab (TCZ), a humanized anti-IL-6R antibody [37]. Here, IKZF2 is linked to rheumatoid arthritis.